Kagihara, J. A., Andress, M., & Diamond, J. R. (2020). Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: Review and future directions. Expert Rev Precis Med Drug Dev.
Chicago-stil citatKagihara, Jodi A., Michelle Andress, och Jennifer R. Diamond. "Nab-paclitaxel and Atezolizumab for the Treatment of PD-L1-positive, Metastatic Triple-negative Breast Cancer: Review and Future Directions." Expert Rev Precis Med Drug Dev 2020.
MLA-referensKagihara, Jodi A., Michelle Andress, och Jennifer R. Diamond. "Nab-paclitaxel and Atezolizumab for the Treatment of PD-L1-positive, Metastatic Triple-negative Breast Cancer: Review and Future Directions." Expert Rev Precis Med Drug Dev 2020.